Nothing Special   »   [go: up one dir, main page]

MX2016002507A - Pharmaceutical composition for the combination of desloratadine with montelukast for oral administration via pharmaceutical capsulas for the treatment of respiratory diseases. - Google Patents

Pharmaceutical composition for the combination of desloratadine with montelukast for oral administration via pharmaceutical capsulas for the treatment of respiratory diseases.

Info

Publication number
MX2016002507A
MX2016002507A MX2016002507A MX2016002507A MX2016002507A MX 2016002507 A MX2016002507 A MX 2016002507A MX 2016002507 A MX2016002507 A MX 2016002507A MX 2016002507 A MX2016002507 A MX 2016002507A MX 2016002507 A MX2016002507 A MX 2016002507A
Authority
MX
Mexico
Prior art keywords
pharmaceutical
oral administration
capsulas
desloratadine
montelukast
Prior art date
Application number
MX2016002507A
Other languages
Spanish (es)
Inventor
Daniel Walls Flores Oliver
San Juan Vázquez Armenta Daniela
Rodríguez Hernández Ramón
Original Assignee
Laboratorios Liomont S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liomont S A De C V filed Critical Laboratorios Liomont S A De C V
Priority to MX2016002507A priority Critical patent/MX2016002507A/en
Publication of MX2016002507A publication Critical patent/MX2016002507A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention consists of a pharmaceutical composition for oral administration and useful for the treatment related to respiratory diseases, which is lactose-free and of its derivatives, and also free of antioxidant agents.
MX2016002507A 2016-02-26 2016-02-26 Pharmaceutical composition for the combination of desloratadine with montelukast for oral administration via pharmaceutical capsulas for the treatment of respiratory diseases. MX2016002507A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2016002507A MX2016002507A (en) 2016-02-26 2016-02-26 Pharmaceutical composition for the combination of desloratadine with montelukast for oral administration via pharmaceutical capsulas for the treatment of respiratory diseases.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2016002507A MX2016002507A (en) 2016-02-26 2016-02-26 Pharmaceutical composition for the combination of desloratadine with montelukast for oral administration via pharmaceutical capsulas for the treatment of respiratory diseases.

Publications (1)

Publication Number Publication Date
MX2016002507A true MX2016002507A (en) 2017-08-25

Family

ID=60157960

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016002507A MX2016002507A (en) 2016-02-26 2016-02-26 Pharmaceutical composition for the combination of desloratadine with montelukast for oral administration via pharmaceutical capsulas for the treatment of respiratory diseases.

Country Status (1)

Country Link
MX (1) MX2016002507A (en)

Similar Documents

Publication Publication Date Title
PH12016501966A1 (en) Compounds and compositions as toll-like receptor 7 agonists
NZ724878A (en) Compounds and compositions as toll-like receptor 7 agonists
MA39828A (en) Medical use
EA202090683A3 (en) METHODS AND COMPOSITIONS FOR CANCER TREATMENT
MX2015010829A (en) Therapeutic compounds and uses thereof.
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
MX2018012618A (en) Oral pharmaceutical compositions of mesalazine.
BR112016024235A2 (en) pharmaceutical compositions comprising antibacterial agents
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
GEP20186908B (en) P-substituted asymmetric ureas and medical uses thereof
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
MX2016002507A (en) Pharmaceutical composition for the combination of desloratadine with montelukast for oral administration via pharmaceutical capsulas for the treatment of respiratory diseases.
MX2016002509A (en) Pharmaceutical composition for the combination of desloratadine with montelukast for oral administration via pharmaceutical tablet or granular for the treatment of respiratory diseases.
PH12016502107A1 (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
EA038580B9 (en) Steroid derivative fxr agonist
TR201719926A2 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PHARMACEUTICALLY ACCEPTABLE LITHIUM SALTS AND VITAMIN C
BR112017003900A2 (en) testosterone formulations and treatment methods with them
IN2013MU03838A (en)
BR112017003425A2 (en) pharmaceutical composition for the treatment of acute dental or mandibular pain
PL409015A1 (en) N-sulfonic derivative of polyallylamine, application of N-sulfonic derivative of polyallylamine as a medicine, preferably for the prevention and treatment of infection of respiratory tract induced by the human metapneumovirus (hMPV) and the pharmaceutical composition containing the N-sulfonic derivate of polyallylamine
MX366763B (en) PHARMACEUTICAL COMPOSITIONS OF MONTELUKAST and LEVOCETIRIZINE.
MX2017005669A (en) Benzylhydroxyde derivatives, preparation thereof and therapeutic use thereof.